QATCH Technologies

Executive Summary

QATCH Technologies is a life-science instrumentation startup commercializing proprietary sensor technology from Duke University for measuring viscosity and injectability of biopharmaceutical formulations. Its high-throughput, micro-volume platform aims to de-risk preclinical drug development, particularly for subcutaneous injections of high-concentration biologics. Founded in 2015 and based in Raleigh, NC, the company is currently in the pre-clinical stage with no disclosed funding or revenue. The platform addresses a critical need in biologics formulation, where viscosity and injectability can impact drug delivery and patient outcomes. By enabling rapid, low-volume analysis, QATCH's technology could accelerate candidate selection and reduce late-stage failures. However, as an early-stage private company, it faces challenges in commercialization, regulatory validation, and market adoption.

Upcoming Catalysts (preview)

• Q4 2026Commercial product launch of first sensor system40% success
• Q3 2026Strategic partnership or licensing deal with a major biopharma company30% success
• Q2 2026Series A funding round to accelerate development and commercialization50% success